Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.

[1]  J. Baum,et al.  Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .

[2]  A. Pinna,et al.  Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections , 1999, The British journal of ophthalmology.

[3]  Savitri Sharma,et al.  Ciprofloxacin-resistant Pseudomonas keratitis. , 1999, Ophthalmology.

[4]  N. Morlet,et al.  Routine antibiotic sensitivity testing for corneal ulcers. , 1998, Archives of ophthalmology.

[5]  Forster Rk.  Conrad Berens Lecture. The management of infectious keratitis as we approach the 21st century. , 1998 .

[6]  R. Forster.  The management of infectious keratitis as we approach the 21(st) century , 1998 .

[7]  S. Spisak,et al.  The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic. , 1997, Ophthalmology.

[8]  M. Marsh,et al.  The role of cultures in the management of ulcerative keratitis. , 1997, Cornea.

[9]  E. Cohen,et al.  Use of routine antibiotic sensitivity testing for the management of corneal ulcers. , 1997, Archives of ophthalmology.

[10]  E. Cohen,et al.  Trends in contact lens-associated corneal ulcers. , 1996, Cornea.

[11]  V. Klauss,et al.  Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. , 1996, Ophthalmology.

[12]  K. Bower,et al.  Fluoroquinolones in the treatment of bacterial keratitis. , 1996, American journal of ophthalmology.

[13]  M. Viana,et al.  Differential care of corneal ulcers in the community based on apparent severity. , 1996, Ophthalmology.

[14]  I. C. Lloyd,et al.  Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. , 1996, Ophthalmology.

[15]  P M Southern,et al.  Susceptibility of Corneal and Conjunctival Pathogens to Ciprofloxacin , 1996, Cornea.

[16]  M. Maguire,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. , 1995, Archives of ophthalmology.

[17]  J. Dart,et al.  Strategies for the management of microbial keratitis. , 1995, The British journal of ophthalmology.

[18]  D. O'day,et al.  Ciprofloxacin-resistant bacterial keratitis. , 1993, American journal of ophthalmology.

[19]  J. Aquavella,et al.  Community care of corneal ulcers. , 1992, American journal of ophthalmology.

[20]  M. Snyder,et al.  Ciprofloxacin-resistant bacterial keratitis. , 1992, American journal of ophthalmology.

[21]  Neu Hc.  Microbiologic aspects of fluoroquinolones. , 1991 .

[22]  E. Alfonso,et al.  Ulcerative keratitis associated with contact lens wear. , 1989, American journal of ophthalmology.

[23]  T. Liesegang,et al.  Spectrum of microbial keratitis in South Florida. , 1980, American journal of ophthalmology.

[24]  J. Baum.  Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms. , 1979, Survey of ophthalmology.

[25]  D. Jones,et al.  Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. , 1979, Survey of ophthalmology.

[26]  R. Forster,et al.  Diagnostic limulus lysate assay for endophthalmitis and keratitis. , 1978, Archives of ophthalmology.

[27]  Savitri Sharma,et al.  In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. , 1999, Ophthalmology.